Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021.


Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 07 03 2022
received: 18 01 2022
accepted: 21 03 2022
pubmed: 27 3 2022
medline: 30 9 2022
entrez: 26 3 2022
Statut: ppublish

Résumé

Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small.

Identifiants

pubmed: 35338581
doi: 10.1111/tbed.14534
pmc: PMC9115462
doi:

Substances chimiques

Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3244-e3249

Informations de copyright

© 2022 Crown copyright. Transboundary and Emerging Diseases published by Wiley-VCH GmbH. This article is published with the permission of the Controller of HMSO and the Queen's Printer for Scotland.

Références

J Virol. 2005 Feb;79(3):1595-604
pubmed: 15650185
Emerg Infect Dis. 2021 Apr;27(4):1015-1022
pubmed: 33770472
Nature. 2022 Feb;602(7897):481-486
pubmed: 34942632
Microbiol Spectr. 2022 Apr 27;10(2):e0057622
pubmed: 35319276
J Virol. 2006 Jul;80(14):7270-4
pubmed: 16809333
Microorganisms. 2021 Apr 17;9(4):
pubmed: 33920724
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):
pubmed: 34732584
J Virol. 2021 Mar 10;:
pubmed: 33692203
Transbound Emerg Dis. 2022 Sep;69(5):e3244-e3249
pubmed: 35338581
PLoS Pathog. 2022 Mar 21;18(3):e1010197
pubmed: 35312736
Vector Borne Zoonotic Dis. 2022 Jan;22(1):62-64
pubmed: 34890284
Viruses. 2020 Nov 16;12(11):
pubmed: 33207802
Mol Phylogenet Evol. 2004 Dec;33(3):880-95
pubmed: 15522810
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Emerg Infect Dis. 2020 Jan;26(1):90-96
pubmed: 31661056
Rev Sci Tech. 1998 Aug;17(2):469-526
pubmed: 9713892
Lancet Microbe. 2021 Dec;2(12):e646-e647
pubmed: 34778852
Science. 2021 Mar 26;371(6536):1306-1308
pubmed: 33766871

Auteurs

Maya Holding (M)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.

Ashley David Otter (AD)

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.

Stuart Dowall (S)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.

Katsuhisa Takumi (K)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Bethany Hicks (B)

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.

Tom Coleman (T)

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.

Georgia Hemingway (G)

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.

Matthew Royds (M)

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.

Stephen Findlay-Wilson (S)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.

Mollie Curran-French (M)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.

Richard Vipond (R)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.

Hein Sprong (H)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Roger Hewson (R)

Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH